Close
Achema middle east
swop processing & packaging

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2016

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

UK Exchequer Wants More Pharma Investment Coming in Britain

Rachel Reeves, the UK Chancellor of the Exchequer, has...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry...

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2016 of $0.80 per share on the company’s common stock. The dividend is payable on September 6, 2016 to shareholders of record at the close of business on August 23, 2016. The ex-dividend date is August 19, 2016. 

 

About Johnson & Johnson 
Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,500 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. 

Press Contacts:

Ernie Knewitz 

(732) 524-6623 

(917) 697-2318 (M) 

 

Amy Jo Meyer

732-524-6678

908-616-6250 (M) 

 

Investor Contacts:

Louise Mehrotra

(732) 524-6491

 

Lesley Fishman 

(732) 524-3922

 

Latest stories

Related stories

UK Exchequer Wants More Pharma Investment Coming in Britain

Rachel Reeves, the UK Chancellor of the Exchequer, has...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry...

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »